การพัฒนาระบบ อสม. Delivery Drugs ของยา Favipiravir, Molnupiravir และ ฟ้าทะลายโจร ในช่วงการระบาดของโควิด โดยโรงพยาบาลกุดชุม จังหวัดยโสธร

Abstract

This study aims to develop a system for dispensing Favipiravir, Molnupiravir, and Andrographis paniculata by Village Health Volunteers, Delivery Drugs, to patients infected with COVID-19 in the community, with drugs being delivered according to the hospital's outpatient care system. So that patients can receive medicine quickly to prevent the spread and infection without having to come to receive services at community hospitals, reduce congestion and the spread of infection to patients who come to receive services. It is the coordination of community hospitals. Primary service units and village health volunteers. Delivering medicine to COVID patients in their area on a motorbike the same day they tested positive for COVID-19. The educational format is R2R. By collecting performance results together with network partners in the area. and recording data through the HOSxP system to follow up on the development of the drug distribution system for a period of 3 months. Between 21 March and 20 June 2022 with ATK and rt-PCR results using the specific selection method of all 13 primary public health hospitals. Data were analyzed using frequencies. Percentage of medication errors  and analysis of Kruskal willis test, Chi-square test, gender, age, treatment eligibility for COVID-19 drug treatment.

The results of the study found that the majority of patients were female, with an average age of 48 years, receiving outpatient treatment, a total of 4,094 people. Patients over 60 years old, accounting for 26.85%, received Favipiravir, 54.09% found 21 medication errors. times, accounting for 0.51 percent. Patients received medicine on the day of COVID-19 diagnosis: 4,079, accounting for 99.63 percent. Cost of drug delivery per person per time 28.17 baht. Developing a COVID-19 drug delivery system by connecting in the context of community hospitals Primary care unit and public health volunteers help in delivering the said medicines: The system is efficient, fast and low cost. This is an advantage over sending medicine by post which cannot be sent in this way. Highlights of this research It is one of the first studies to develop a COVID drug delivery system to COVID 2019 patients. By a multidisciplinary team. In the situation of the COVID-19 outbreak in the context of community hospitals and public health hospitals, this is different from past research in Thailand, which often studied large hospitals that focused on adjusting service systems to reduce crowding. sick And this study has the advantage of studying the effectiveness of the drug and infected patients in the area.